A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Bäuerlein, Carina A ^a,b,c   Riedel, Simone S ^a,b,c   Baker, Jeanette ^a,b,c,d   Brede, Christian ^a,b,c   Garrote, Ana Laura J ^a,b,c   Chopra, Martin ^a,b   Ritz, Miriam ^a,b   Beilhack, Georg F ^e   Schulz, Stephan ^f   Zeiser, Robert ^g   Schlegel, Paul G ^c,h   Einsele, Hermann ^a,c   Negrin, Robert S ^d   Beilhack, Andreas ^a,b,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Interdisciplinary Center for Clinical Research (IZKF)   (Germany)

^c Graduate School of Life Sciences   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Allogeneic stem cell transplantation; Graft versus host disease; Minor histocompatibility antigen mismatch transplantation

Indexed keywords

ALPHA4 INTEGRIN; ALPHA4BETA7 INTEGRIN; MINOR HISTOCOMPATIBILITY ANTIGEN; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DONOR; ENGRAFTMENT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RECIPIENT; UPREGULATION; WEIGHT CHANGE;

ACUTE DISEASE; ANIMALS; BLOOD GROUP INCOMPATIBILITY; DISEASE MODELS, ANIMAL; FEMALE; FORECASTING; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84878345120     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-134     Document Type: Article

References (25)

1. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature 2001, 411:385-389. 10.1038/35077251, 11357147.
2. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991, 324:667-674. 10.1056/NEJM199103073241005, 1994250.
3. Beilhack A, Schulz S, Baker J, Beilhack GF, Nishimura R, Baker EM, Landan G, Herman EI, Butcher EC, Contag CH, Negrin RS. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 2008, 111:2919-2928. 10.1182/blood-2007-09-112789, 2254542, 17989315.
4. Panoskaltsis-Mortari A, Price A, Hermanson JR, Taras E, Lees C, Serody JS, Blazar BR. In vivo imaging of graft-versus-host-disease in mice. Blood 2004, 103:3590-3598. 10.1182/blood-2003-08-2827, 14715632.
5. Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao Y-A, Contag CH, Negrin RS. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005, 106:1113-1122. 10.1182/blood-2005-02-0509, 1895168, 15855275.
6. Korngold R, Sprent J. Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex. J Exp Med 1980, 151:1114-1124. 10.1084/jem.151.5.1114, 2185864, 6966318.
7. Cao Y-A, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci USA 2004, 101:221-226. 10.1073/pnas.2637010100, 314166, 14688412.
8. Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, Herzenberg LA, Herzenberg LA. Modern flow cytometry: a practical approach. Clin Lab Med 2007, 27:453-468. 10.1016/j.cll.2007.05.001, 1994577, 17658402.
9. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawford JM, Ferrara JL. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996, 88:3230-3239.
10. Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS. Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008, 111:453-462. 10.1182/blood-2007-06-094482, 2200823, 17967941.
11. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974, 6:367-371.
12. Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MRM. LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 2004, 103:1542-1547.
13. Lu SX, Holland AM, Na I-K, Terwey TH, Alpdogan O, Bautista JL, Smith OM, Suh D, King C, Kochman A, Hubbard VM, Rao UK, Yim N, Liu C, Laga AC, Murphy G, Jenq RR, Zakrzewski JL, Penack O, Dykstra L, Bampoe K, Perez L, Furie B, Furie B, van den Brink MRM. Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease. J Immunol 2010, 185:1912-1919. 10.4049/jimmunol.0903148, 20622117.
14. Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J. Up-regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:1066-1076. 10.1016/j.bbmt.2009.05.003, 2945817, 19660719.
15. Tsuchiyama J, Yoshino T, Saito T, Furukawa T, Ito K, Fuse I, Aizawa Y. Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA + T- and NK-cell fractions. Bone Marrow Transplant 2008, 43:863-873.
16. Chen YB, McDonough S, Chen H, Kennedy J, Illiano C, Attar EC, Ballen KK, Dey BR, McAfee SL, Jagasia M, Soiffer R, Spitzer TR, Ritz J. Expression of alpha4beta7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD. Bone Marrow Transplant 2013, 48:598-603. 10.1038/bmt.2012.191, 23042495.
17. Waldman E, Lu SX, Hubbard VM, Kochman AA, Eng JM, Terwey TH, Muriglan SJ, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MRM. Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. Blood 2006, 107:1703-1711. 10.1182/blood-2005-08-3445, 1895413, 16291587.
18. Levine JE, Logan BR, Wu J, Alousi AM, Bolanos-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood 2012, 119:3854-3860. 10.1182/blood-2012-01-403063, 3335389, 22383800.
19. Harris AC, Ferrara JL, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Landfried K, Akashi K, Vander Lugt M, Couriel DR, Reddy P, Paczesny S. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood 2012, 119:2960-2963. 10.1182/blood-2011-10-387357, 3327467, 22286196.
20. Chen BJ, Morris RE, Chao NJ. Graft-versus-host disease prevention by rapamycin: cellular mechanisms. Biol Blood Marrow Transplant 2000, 6:529-536. 10.1016/S1083-8791(00)70062-0, 11071258.
21. Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J, Contag CH, Negrin RS. Inhibition of CD4 + CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006, 108:390-399. 10.1182/blood-2006-01-0329, 1895845, 16522809.
22. Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004, 104:340-349. 10.1182/blood-2004-02-0518, 15054046.
23. Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JL. A biomarker panel for acute graft-versus-host disease. Blood 2009, 113:273-278. 2615645, 18832652.
24. Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara JL. Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med 2010, 2:13ra2. 10.1126/scitranslmed.3000406, 2895410, 20371463.
25. Reshef R, Luger SM, Hexner EO, Loren AW, Frey NV, Nasta SD, Goldstein SC, Stadtmauer EA, Smith J, Bailey S, Mick R, Heitjan DF, Emerson SG, Hoxie JA, Vonderheide RH, Porter DL. Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med 2012, 367:135-145. 10.1056/NEJMoa1201248, 3568501, 22784116.